Medical research

A new paradigm for cosmetic products without animal testing

According to the European Union (EU) Cosmetics Regulation, animal testing for the risk assessment of cosmetic products or their ingredients is prohibited in the EU and all its member countries. The regulation includes an ...

Vaccination

Once lagging, Europe catches up to the US in vaccinations

Despite a sluggish start, the European Union's COVID-19 vaccination drive has caught up to that of the United States, where the slowdown of the country's once-vaunted campaign has contributed to the virus's deadly comeback.

Vaccination

Germany plans Covid booster shots from September: draft text

Germany plans to start offering COVID-19 booster shots to the elderly and at-risk from September 1, according to a draft document seen by AFP on Sunday, as concerns grow about the spread of the Delta variant.

Vaccination

EU hits goal of delivering vaccines for 70% of adults

The European Union has hit its target of delivering enough coronavirus vaccine to cover 70 percent of the adult population, EU Commission President Ursula von der Leyen said Saturday.

Diseases, Conditions, Syndromes

Delta variant casts shadow over EU COVID travel pass

An EU-wide COVID certificate for easier travel came into force on Thursday, just in time for Europe's busy summer vacation period—but the highly infectious Delta variant is already threatening to curtail its use.

Diseases, Conditions, Syndromes

Double COVID jab seems to curb Delta variant: EMA

Two doses of COVID vaccine appear to provide protection against the rapidly spreading Delta variant, the European Medicines Agency said Thursday.

Diseases, Conditions, Syndromes

Delta variant to account for 90% of new EU COVID cases: agency

The Delta variant, identified for the first time in India, could account for 90 percent of new COVID cases in the European Union in the coming months, the bloc's disease control agency said Wednesday.

Diseases, Conditions, Syndromes

Interim trial data shows low effectiveness for CureVac shot

German vaccine maker CureVac said Wednesday that interim data from late-stage testing of its coronavirus shot show a comparatively low effectiveness in protecting people against COVID-19.

page 13 from 40